Wright Medical Group completed its acquisition of BioMimetic Therapeutics, a deal which began back in November, for about $190 million, according to Zacks.
Medical device maker Wright Medical Group has agreed to buy BioMimetic Therapeutics for $380 million and has reached a financial agreement with Sam Lynch, MD, BioMimetic CEO, according to the Nashville Business Journal.
Medical device manufacturer Wright Medical Group has agreed to purchase BioMimetic Therapeutics for up to $380 million, according to Memphis Business Journal.
Wright Medical Group launched the MiToe patient outreach program to increase awareness for treatment options of hammertoes.
Wright Medical Group reported a 6 percent decrease in first quarter net sales to $126.7 million, driven by previously announced distributor transitions and challenges associated with the company's compliance processes.
Wright Medical Group announced its full commercial launch of the CLAW II Polyaxial Compression System featuring the ORTHOLOC 3DSi Polyaxial Locking Screw Technology.
Wright Medical Group named James A. Lightman senior vice president, general counsel and secretary.
Wright Medical Group announced the full commercial launch of its CLAW II Polyaxial Compression Plating System featuring ORTHOLOC 3DSi Polyaxial Locking Screw Technology.
Wright Medical Group announced fourth quarter net sales at $126.9 million, an 8 percent decrease over the same period last year.
Wright Medical Group has received FDA 510(k) Clearance for its PROPHECY INBONE Pre-Operative Navigation Alignment Guides for total ankle replacement, according to a company news release.
  • «
  •  Prev 
  •  1 
  •  2 
  •  3 
  •  Next 
  • »
Page 1 of 3